opioid addiction

AvertD, a genetic test designed to detect which people are at heightened risk of opioid use disorder (OUD), has sparked controversy within medical circles. Despite its recent approval by the FDA, a coalition of 31 healthcare professionals and researchers is urging a reconsideration of its validity and potential implications. They say the test causes false